Sort
85,873 grants matching “alzheimers”
Clinical Core B
$886,843Douglas R Galasko · University Of California, San Diego · P50 · FY2013 · AG
Neurocognitive Impairment Assessment in Symptomatic Carotid  Occlusion Recanalized Endovascularly: NIA SCORE
$886,752David M. Hasan · University Of Iowa · R01 · FY2020 · AG
Brain Vulnerability in Delirium and Alzheimerâs Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation
$886,675Sarinnapha Vasunilashorn · Beth Israel Deaconess Medical Center · R01 · FY2023 · AG
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$886,543Andrew I Su · Scripps Research Institute, The · R01 · FY2022 · AG
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$886,543Andrew I Su · Scripps Research Institute, The · R01 · FY2021 · AG
Imaging Neuroinflammation in Alzheimer's Disease (AD) with [11C]Arachidonic Aci
$886,509Shankar Vallabhajosula · Weill Medical Coll Of Cornell Univ · RC2 · FY2010 · AG
Aging in 1000 healthy midlife adults: Phase 52 of the Dunedin Study
$886,459Terrie Edith Moffitt · Duke University · R01 · FY2023 · AG
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
$886,421Emily J Rogalski · Northwestern University At Chicago · R01 · FY2021 · AG
Genetic Contribution to Brain Arterial Dilatation and its Role in Cognition and dementia
$886,375Jose Gutierrez · Columbia University Health Sciences · R01 · FY2021 · AG
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia
$886,282Fei Du · Mclean Hospital · R01 · FY2023 · AG
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia
$886,282Fei Du · Mclean Hospital · R01 · FY2022 · AG
Epidemiology of Dementia in the Framingham Study
$886,133Philip A Wolf · Boston University Medical Campus · R01 · FY2008 · AG
Neuroimaging and Plasma Biomarkers Core
$886,119Ilya M Nasrallah · Columbia University Health Sciences · U19 · FY2022 · AG
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$885,966Andrew I Su · Scripps Research Institute, The · R01 · FY2023 · AG
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$885,874Andrew I Su · Scripps Research Institute, The · R01 · FY2020 · AG
Epidemiology of Functional Status in Elderly Hispanics
$885,827Mary N. Haan · University Of California, San Francisco · R01 · FY2011 · AG
EPIDEMIOLOGY AND GENETICS OF PARKINSON'S DISEASE
$885,733Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · NS
Preventing Tau uptake by novel inhibitors of tau binding to LRP1
$885,722Kenneth S Kosik · University Of California Santa Barbara · R01 · FY2022 · AG
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
$885,611Stuart A Lipton · Scripps Research Institute, The · R56 · FY2020 · AG
Clin-STAR Coordinating Center
$885,537Odette Van Der Willik · American Federation For Aging Research · U24 · FY2021 · AG
Mechanisms of neurotransmitter release and its regulation
$885,526Jose Rizo-Rey · Ut Southwestern Medical Center · R35 · FY2018 · NS
Mechanisms of neurotransmitter release and its regulation
$885,526Jose Rizo-Rey · Ut Southwestern Medical Center · R35 · FY2020 · NS
Mechanisms of neurotransmitter release and its regulation
$885,526Jose Rizo-Rey · Ut Southwestern Medical Center · R35 · FY2022 · NS
Mechanisms of neurotransmitter release and its regulation
$885,526Jose Rizo-Rey · Ut Southwestern Medical Center · R35 · FY2019 · NS
Mechanisms of neurotransmitter release and its regulation
$885,526Jose Rizo-Rey · Ut Southwestern Medical Center · R35 · FY2021 · NS